Aptar Pharma launches new respiratory device at CPhI Worldwide

Drug delivery systems provider, Aptar Pharma, has launched its new portable respiratory device at CPhI Worldwide.

The company has showcased its PureHale product, a drug delivery device designed for upper respiratory care.

Aptar Pharma has also revealed a range of new connected drug delivery devices designed to increase dose adherence and improve patient outcomes; a portfolio of gamma-sterilised drug delivery components; and a support services initiative to help customers get their molecules to market.

Guillaume Brouet, vice president Analytical, Regulatory and Scientific Affairs at Aptar Pharma, said: “Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies.”

Lastly, the company has showcased its portfolio of drug delivery devices that address and range of conditions, as well as new solutions in prescriptions and over-the-counter treatments.

You can find Aptar Pharma at its stand 4D10.